跳至主要内容
临床试验/NCT03194230
NCT03194230已完成不适用

Interest of Cervical Dilators in the Induction of Labor in Second Trimester Medical Termination of Pregnancy.

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 355 人开始时间: 2017年12月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
355
试验地点
1
主要终点
Proportion of women achieving vaginal delivery within 12 hours

研究概览

简要总结

The purpose of this study is to evaluate whether the use of cervical dilators for cervical ripening in case of second trimester medical termination of pregnancy (TOP) is effective to reduce duration of labor.

详细描述

Termination of pregnancy is a distressing and painful procedure for women. The use of cervical dilators could shorten the duration of labor but can generate more pain. The investigators will compare two procedures of induction of labor for second trimester termination of pregnancy: one with the use of oral prostaglandins (misoprostol) only and one with the exact same procedure preceded by cervical ripening with hygroscopic cervical dilators. Epidural analgesia will be effective previously to the placement of cervical dilators and the first tablet of misoprostol. Efficacy will be determined based on the proportion of women achieving vaginal delivery within 12 hours. The beginning of labor will be defined as the first administration of misoprostol tablets in both groups.

The investigators will also evaluate safety by collecting hemorrhage endometritis, cervical tear. The investigators will compare psychological impact of these procedures, measured by the impact of event scale and acceptability 1 to 4 months later.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Termination of pregnancy requested by the patient and accepted by the weekly multidisciplinary counselling of fetal medicine
  • •gestational age between 15 and 27 weeks and 6 days,
  • •single pregnancy,
  • •major patient,
  • •French-speaking woman,
  • •Patient with health insurance.

排除标准

  • •Termination of pregnancy by surgical technique
  • •cicatricial uterus
  • •premature rupture of membranes
  • •chorioamnionitis
  • •multiple pregnancy
  • •placenta praevia
  • •myoma praevia
  • •uterine malformation
  • •unstable maternal pathology
  • •psychiatric pathology
  • •contraindication to mifepristone: severe asthma, adrenal insufficiency, porphyria, corticotherapy.
  • •contraindication to misoprostol: hypersensitivity to prostaglandins.
  • •contraindication to epidural analgesia: hemostasis disorder, spinal or medullary anomaly.
  • •Bishop score > or = to 7 at arrival in birth room

研究组 & 干预措施

Without cervical dilator

No Intervention

Induction of labour by oral of 400µg of misoprostol each 3 hours.

With cervical dilator

Experimental

Induction of labour by cervical placement of hygroscopic dilators for 3 hours and oral of 400µg tablets of misoprostol each 3 hours.

干预措施: With cervical dilatator (Other)

结局指标

主要结局

Proportion of women achieving vaginal delivery within 12 hours

时间窗: 12 hours

The beginning of labor will be defined as the placement of the first tablets of misoprostol in both groups.

次要结局

  • Induction-to-amniotomy interval(12 hours)
  • Assessment of acceptability of the whole procedure of TOP(4 months)
  • Induction-to-delivery interval(24 hours)
  • Failure in induction of labor(24 hours)
  • Pain assessment at the beginning of the procedure(Hour 0)
  • Pain assessment of the whole procedure of TOP(48 hours)
  • Distress assessment at discharge after TOP(4 months)
  • number of complications.(4 months)
  • Duration of hospitalization.(48 hours)
  • Cost of the procedure(4 months)
  • Among nullipara, proportion of women achieving vaginal delivery within 12 hours(12 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验